<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Isolated left ventricular noncompaction in adults: Clinical manifestations and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Isolated left ventricular noncompaction in adults: Clinical manifestations and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Isolated left ventricular noncompaction in adults: Clinical manifestations and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christine H Attenhofer-Jost, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Heidi M Connolly, MD, FACC, FASE</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William J McKenna, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 05, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H433605014"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Left ventricular noncompaction (LVNC, also known as noncompaction cardiomyopathy [<a href="#rid1">1</a>]) is a complex myocardial disorder with a distinct phenotype characterized by prominent LV trabeculae and deep intertrabecular recesses [<a href="#rid2">2,3</a>]. LVNC was previously also called spongy myocardium or hypertrabeculation syndrome but these terms should not be used interchangeably with LVNC [<a href="#rid4">4</a>].</p><p>This review will focus on clinical manifestations and diagnosis of LVNC as an isolated disorder distinct from other clinical settings in which non-compacted myocardium may be seen in association with other cardiac and noncardiac abnormalities. Management and prognosis of isolated LVNC is discussed separately. (See  <a class="medical medical_review" href="/d/html/120616.html" rel="external">"Isolated left ventricular noncompaction in adults: Management and prognosis"</a>.)</p><p class="headingAnchor" id="H1"><span class="h1">DEFINITIONS</span><span class="headingEndMark"> — </span>LVNC is a phenotype resulting from a genetic trait associated with various cardiomyopathies, congenital heart disease, and/or environmental effects [<a href="#rid5">5</a>]. LVNC has been categorized as an "unclassified" cardiomyopathy  (<a class="graphic graphic_table graphicRef64479 graphicRef74268" href="/d/graphic/64479.html" rel="external">table 1A-B</a>) [<a href="#rid3">3</a>], but mounting evidence now points to reclassification of LVNC as a distinct but not always pathological phenotype. The presence of noncompacted myocardium by itself does not seem to cause disease. By definition, isolated LVNC occurs in the absence of other cardiac or noncardiac congenital abnormalities. (See  <a class="medical medical_review" href="/d/html/4943.html" rel="external">"Definition and classification of the cardiomyopathies"</a> and <a class="local">'Differential diagnosis'</a> below.)</p><p>LVNC is characterized by the following features:</p><p class="bulletIndent1"><span class="glyph">●</span>An altered myocardial wall with prominent trabeculae and deep intertrabecular recesses, resulting in thickened myocardium with two layers consisting of noncompacted myocardium and a thin compacted layer of myocardium  (<a class="graphic graphic_picture graphicRef57125" href="/d/graphic/57125.html" rel="external">picture 1</a>) [<a href="#rid6">6-8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Continuity between the LV cavity and the deep intertrabecular recesses, which are filled with blood from the ventricular cavity without evidence of communication to the epicardial coronary artery system.</p><p></p><p>As discussed below, criteria for the extent of noncompaction have been developed to help distinguish the trabeculation seen in LVNC from that seen in other forms of heart disease and in healthy individuals. However, criteria are evolving and there may be morphologic overlap between LVNC and other types of cardiomyopathy and other pathologic and nonpathologic phenotypes. (See <a class="local">'Diagnosis'</a> below and <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H3899921211"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>The prevalence of LVNC in the general population is not known and depends on the imaging modality used for diagnosis. The prevalence among patients undergoing echocardiography is estimated at 0.014 to 1.3 percent [<a href="#rid9">9-12</a>]. An earlier review from Switzerland identified 34 cases within 15 years, which represented 0.014 percent of echocardiograms performed [<a href="#rid13">13</a>]. However, this is an underestimate, as improved echocardiographic image quality, increased detection of the entity on nonechocardiographic imaging, and increasing awareness of LVNC lead to enhanced recognition of this phenotype. Among patients with heart failure (HF), the prevalence of LVNC has been reported as 3 to 4 percent [<a href="#rid14">14</a>]. Among patients with HF, criteria for LVNC are more frequently met among Black patients than among White patients [<a href="#rid15">15</a>].</p><p>In a systematic review and meta-analysis of 59 studies in patients ≥12 years old, the prevalence estimate of LVNC by echocardiography was 1.28 percent [<a href="#rid12">12</a>]. By cardiovascular magnetic resonance (CMR) imaging, prevalence was 14.79 percent. By both methods, the LVNC criteria were more often fulfilled in athletes (by echocardiography, 3.16 and by CMR, 27.92 percent). These observations demonstrate the difficulty in ascertaining the prevalence of LVNC, as there are a variety of morphologic criteria applied, and diagnostic criteria for LVNC likely have varying specificity in different populations. As examples, most studies have not included wall thickness &lt;8.1 mm as a criterion, and the morphology of papillary muscles has seldom been addressed. Additionally, the ethnicity or gravid state of the patient has to be considered. Diagnosis of noncompaction should be reserved for obvious pathology, especially in the setting of family history of cardiomyopathy, arrhythmias, or symptoms. Studies have shown a high rate of false positives with CMR imaging [<a href="#rid16">16</a>], suggesting that CMR criteria for LVNC require improvement to avoid overestimation of prevalence.</p><p>LVNC is rarely reported in children, although the reported incidence may be an underestimate. In children, LVNC occurs mainly in association with congenital heart disease such as ventricular septal defect, atrial septal defect, patent ductus arteriosus, Ebstein anomaly, aortic stenosis, and coarctation of the aorta.</p><p class="headingAnchor" id="H433605363"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>It has been suggested that LVNC may be due to intrauterine arrest of compaction of the loose interwoven meshwork that makes up the fetal myocardial primordium. However, the term "noncompaction" may be a misnomer: some authors have suggested that noncompaction of the ventricular myocardium results from abnormal persistence of the trabecular layer, rather than from noncompaction of the ventricular wall [<a href="#rid17">17</a>]. Pronounced hypertrabeculation may be the result of altered regulation in cell proliferation, differentiation, and maturation during ventricular wall formation [<a href="#rid18">18</a>]. Trabeculations of the LV may be unique for each individual, like fingerprints [<a href="#rid19">19</a>].</p><p>Prominent trabeculations as seen in LVNC may develop during adult life. Remodeling in response to LV loading conditions may explain the phenotypic characteristics of LVNC seen in some athletes and in some individuals who are hypertensive, pregnant, or have HF or hematologic disorders (eg, β-thalassemia) [<a href="#rid8">8,20</a>]. Additionally, LVNC can occur as a transient phenomenon in patients with other disorders, such as myocarditis. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H3"><span class="h1">GENETICS</span><span class="headingEndMark"> — </span>LVNC can be either sporadic or familial. In various reports, 12 to 50 percent of those with LVNC had a family history of LVNC [<a href="#rid7">7,13</a>]. Other affected individuals can be detected by screening asymptomatic relatives of affected patients [<a href="#rid21">21</a>]. Autosomal dominant inheritance is more common than X-linked inheritance or autosomal recessive inheritance [<a href="#rid22">22</a>]. Differentiation of genotypes is not possible on the basis of current phenotypic data. The yield of genetic testing in patients with LVNC is around 30 to 50 percent [<a href="#rid23">23,24</a>]. Genetic testing is recommended, especially in the presence of additional myocardial abnormalities, syndromic features, or a family history of cardiomyopathy [<a href="#rid24">24</a>].</p><p>There is increasing recognition of considerable overlap in the genetic loci implicated in the major cardiomyopathies. Shared molecular etiology has been found for different cardiomyopathic phenotypes, including overlapping phenotypes between LVNC and hypertrophic cardiomyopathy (HCM) [<a href="#rid25">25</a>] and between LVNC and apical HCM [<a href="#rid26">26</a>]. Despite the genetic overlap between LVNC and HCMs, LVNC co-occurs more commonly than HCM in patients with congenital heart disease or Wolff-Parkinson-White syndrome.</p><p class="headingAnchor" id="H4"><span class="h2">Identified genes and their clinical significance</span><span class="headingEndMark"> — </span>In patients with LVNC, a wide variety of gene mutations have been reported, primarily in genes coding for sarcomeric, cytoskeletal, Z-line, and mitochondrial proteins. The most common mutations involve sarcomeric proteins (82 percent) [<a href="#rid27">27</a>]. In a systematic review including 561 patients from 17 studies, variants in 66 genes in patients with LVNC were described [<a href="#rid28">28</a>], including genes encoding beta-myosin heavy chain (<em>MYH7</em>), titin (<em>TTN</em>), hyperpolarization activated cyclic nucleotide gated potassium channel 4 (<em>HCN4</em>), LIM domain binding protein 3 (<em>LDB3</em>), α-dystrobrevin (<em>DTNA</em>), tafazzin (<em>TAZ</em>), lamin A/C (<em>LMNA</em>), alpha-cardiac actin (<em>ACTC</em>), cardiac troponin T (<em>TNNT2</em>), troponin I (<em>TNN13</em>), cardiac myosin binding protein C (<em>MYBPC3</em>), <em>SCN5A</em>, <em>SNTA1</em>, <em>PRDM16</em>, and tropomyosin 1 (<em>TPM1</em>) [<a href="#rid29">29-31</a>]. Most genes associated with LVNC are associated with additional phenotypes (mainly HCM without noncompaction or dilated cardiomyopathy) [<a href="#rid32">32</a>]. Fibrillin-1 gene mutations were identified in 10 percent of patients with LVNC and reduced LV function and/or LV dilation [<a href="#rid33">33</a>]. A study of 327 unrelated adults and children with LVNC found a pathologic mutation in 32 percent [<a href="#rid27">27</a>]. The following are some key mutations associated with LVNC:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sarcomeric protein genes </strong>– A number of sarcomeric protein gene mutations have been identified in patients with LVNC, with <em>MYH7</em> and <em>TTN</em> mutations among the most common [<a href="#rid27">27,28,31</a>]. The <em>E101K</em> mutation in the alpha-cardiac actin gene (<em>ACTC</em>) has been identified in families with LVNC, septal defects, and apical HCM [<a href="#rid34">34</a>]. In a study with 63 unrelated subjects with LVNC, 18 mutations in several sarcomeric protein genes were found (cardiac beta-myosin heavy chain, alpha-cardiac actin, cardiac myosin-binding protein C [<em>MYBPC3</em>], alpha-tropomyosin [<em>TMP1</em>], and troponin T2) [<a href="#rid35">35,36</a>]. A description of cardiac beta-myosin heavy chain defect in two families with LVNC links noncompaction to hypertrophic, restrictive, and dilated cardiomyopathies [<a href="#rid37">37</a>]. Twenty-nine percent of the 63 patients had a sarcomere gene mutation, which did not predict the clinical phenotype [<a href="#rid36">36</a>]. LVNC has also been linked to mutations in tropomyosin 1 [<a href="#rid38">38</a>] and desmin [<a href="#rid39">39</a>]. Titin-truncating variants may be associated with increased risk of HF among patients with LVNC [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tafazzin</strong> – Mutations in the Tafazzin gene (aka G4.5 or <em>TAZ</em>) that result in truncation of tafazzin proteins lead to severe cardiolipin deficiency in the mitochondrial membrane and are responsible for Barth syndrome [<a href="#rid9">9,30,41,42</a>]. Barth syndrome is an X-linked recessive disorder with associated cardiomyopathy, neutropenia, and skeletal myopathy. In a study, 90 percent of patients had a cardiomyopathy, and 53 percent increased LV trabeculations or true LVNC [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/d/html/4912.html" rel="external">"Inherited syndromes associated with cardiac disease", section on 'Barth syndrome'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alpha-dystrobrevin </strong><strong><em>(DTNA</em></strong><strong>) </strong>– A mutation (<em>P121L</em>) in the gene coding for alpha-dystrobrevin, a cytoskeleton protein, has been identified as a rare cause of LVNC, occasionally in conjunction with congenital heart disease [<a href="#rid30">30,42</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional loci –</strong> While most LVNC associated mutations are in sarcomeric, cytoskeletal, Z-line, and mitochondrial proteins, exceptions include a mutation in the NOTCH pathway regulator mindbomb homolog 1 (<em>MIB1</em>) gene (which encodes an E3 ubiquitin ligase) which segregated with autosomal dominant LVNC in two families [<a href="#rid44">44</a>]. Case reports have linked LVNC to additional loci, including lamin A/C [<a href="#rid45">45</a>], Lim Domain Binding 3 (aka Cypher/ZASP) [<a href="#rid42">42,46</a>], and Chromosome 11p15 [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1">A mutation (exon 3 deletion) in the ryanodine receptor gene (<em>RYR2</em>) has been described in patients with LVNC [<a href="#rid31">31</a>], including some who also had a catecholaminergic polymorphic ventricular tachycardia [<a href="#rid48">48</a>].</p><p></p><p class="headingAnchor" id="H2992594295"><span class="h2">Genetic evaluation and family screening</span><span class="headingEndMark"> — </span>The role of genetic evaluation and family screening is discussed separately (See  <a class="medical medical_review" href="/d/html/120616.html" rel="external">"Isolated left ventricular noncompaction in adults: Management and prognosis", section on 'Genetic testing and family screening'</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Clinical manifestations of LVNC are variable and may include dyspnea, chest pain, palpitations, syncope, or an abnormal electrocardiogram (ECG) or echocardiogram [<a href="#rid9">9,13,49</a>]. Cardiac symptoms and signs may not be present. The major complications of LVNC are HF, atrial and ventricular arrhythmias, sudden cardiac arrest, and thromboembolic events, including stroke [<a href="#rid6">6,13,21,50</a>].</p><p class="headingAnchor" id="H1225258770"><span class="h2">Symptoms and signs</span><span class="headingEndMark"> — </span>The frequency of these manifestations at presentation is dependent on the population studied.</p><p>The following report is illustrative. In a systematic review including five studies with a total of 241 adult patients, 56 percent of patients were referred for HF, 27 percent were referred for suspected LVNC based on prior clinical evaluation, and 11 percent were identified by screening [<a href="#rid51">51</a>]. Baseline characteristics included the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Dyspnea – 60 percent</p><p class="bulletIndent1"><span class="glyph">●</span>New York Heart Association (NYHA) functional class III or IV HF – 31 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Palpitations − 18 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Chest pain − 15 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Syncope or presyncope − 9 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Prior stroke – 3 percent</p><p></p><p>An increasing number of patients with isolated LVNC are initially diagnosed during childhood, however, criteria for diagnosis in children have not been established in large studies [<a href="#rid52">52</a>]. Initial diagnosis by prenatal ultrasound has been reported [<a href="#rid53">53</a>]. Similar presenting symptoms and signs have been reported in children [<a href="#rid49">49</a>].</p><p class="headingAnchor" id="H1220014332"><span class="h2">Complications</span><span class="headingEndMark"> — </span>Complications of LVNC include HF, thromboembolism, and arrhythmias.</p><p class="headingAnchor" id="H3874856917"><span class="h3">Heart failure</span><span class="headingEndMark"> — </span>As noted above, among patients with LVNC, symptoms and signs of HF are common at presentation, and hospitalization for HF is common [<a href="#rid51">51</a>]. Patients with LVNC can present as HF with reduced ejection fraction (HFrEF; LV ejection fraction [LVEF] ≤40 percent), or less commonly, HF with preserved ejection fraction (HFpEF: LVEF ≥50 percent) or HF with mid-range ejection fraction (HFmrEF; LVEF 41 to 49 percent). (See <a class="local">'Symptoms and signs'</a> above.)</p><p class="headingAnchor" id="H1225258788"><span class="h3">Thromboembolism</span><span class="headingEndMark"> — </span>The risk of thromboembolism in patients with LVNC has not been established. Given the available data, it is not clear whether the thromboembolic rate in patients with LVNC differs from the rate generally observed in patients with HF. (See  <a class="medical medical_review" href="/d/html/3502.html" rel="external">"Antithrombotic therapy in patients with heart failure"</a>.)</p><p>Case series of patients with LVNC have reported varying rates of thromboembolism. A systematic review of five observational studies with a total of 241 patients (with most patients not anticoagulated) found a mean thromboembolic event (largely cardioembolic stroke but included transient ischemic attack) rate of 8 percent during mean 39-month follow-up, with individual series rates varying from 0 to 24 percent [<a href="#rid51">51</a>]. The highest thromboembolic rate of 24 percent during mean 44-month follow-up was reported in the earliest of the five studies in which anticoagulation use was not specified [<a href="#rid13">13</a>].</p><p>Given the limited number of reported cases, risk factors for thromboembolism in patients with LVNC are uncertain. As an example, one retrospective case series found that 26 of 169 patients with LVNC had a stroke or embolic event during a period of follow-up ranging from less than one to 16 years [<a href="#rid54">54</a>]. Eighteen of the events were felt to be cardioembolic, five atherosclerotic, and three of undetermined cause. Patients with stroke or embolism had higher rates of hypertension and higher CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2-</sub>VASc scores than patients without stroke or embolism. LV fractional shortening was similar in patients with and without a stroke or embolism event. Atrial fibrillation was nominally more frequent in patients with stroke or embolic event but there was no significant difference compared to patients without an event.</p><p class="headingAnchor" id="H628940336"><span class="h3">Arrhythmias</span><span class="headingEndMark"> — </span>Ventricular and atrial arrhythmias occur commonly in patients with LVNC. In a systematic review, 33 percent of patients had nonsustained ventricular tachycardia and 5 percent had sustained ventricular tachycardia [<a href="#rid51">51</a>]. Atrial fibrillation was documented in 10 percent of patients. There are no data on the sudden cardiac death (SCD) risk of athletes with LVNC. LVNC has not been described in autopsy studies of athletes with SCD; however, LVNC could have been missed at autopsy or described as HCM.</p><p class="headingAnchor" id="H4232703233"><span class="h2">Initial testing</span><span class="headingEndMark"> — </span>An ECG is commonly obtained in patients with suspected LVNC. The ECG is usually abnormal (32 of 34 patients in the above report), but findings are nonspecific [<a href="#rid13">13</a>]. The abnormalities that may be seen include left or right bundle branch block, fascicular block, atrial fibrillation, and ventricular tachycardia. Sinus bradycardia or Wolff-Parkinson-White syndrome has been described in up to 18 percent of pediatric patients with LVNC [<a href="#rid9">9,55,56</a>].</p><p>The role of echocardiography and other cardiac imaging in the diagnosis of LVNC is described below. (See <a class="local">'Diagnosis'</a> below.)</p><p class="headingAnchor" id="H11"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H19211077"><span class="h2">When to suspect LVNC</span><span class="headingEndMark"> — </span>Since the clinical presentation of LVNC is nonspecific, a diagnosis of LVNC should be considered in patients with or without cardiac symptoms with prominent trabeculations on cardiac imaging.</p><p class="headingAnchor" id="H2883201193"><span class="h2">Approach to diagnosis</span><span class="headingEndMark"> — </span>LVNC is diagnosed using morphologic criteria which should be applied with caution, particularly in individuals who lack other clinical manifestations of LVNC. Clinical findings are not specific and are thus not diagnostic. The range of LVNC includes severe disease (which dominated early case series) and mild phenotypes that may be difficult to distinguish from normal variants. Preventing mislabeling of healthy individuals and overdiagnosis should be a priority [<a href="#rid57">57</a>].</p><p>We suggest the following approach for diagnosis of LVNC:</p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of LVNC is usually established by identifying morphologic diagnostic criteria on transthoracic echocardiography. We use the Jenni criteria for echocardiographic diagnosis of LVNC (see <a class="local">'Echocardiography'</a> below and <a class="local">'Limitations'</a> below).</p><p></p><p class="bulletIndent1">The Rotterdam criteria of LVNC have been subsequently proposed, which also require absence of septal hypertrophy and presence of cardiac symptoms, family history of HF, sudden cardiac death, abnormal ECG, and/or neuromuscular diseases [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If echocardiography is indeterminate or technically suboptimal, cardiovascular magnetic resonance (CMR) imaging is suggested. Since CMR provides structural details, including evidence of fibrosis and scars, that differ from that provided by echocardiography and may have prognostic value, we perform CMR studies (in addition to echocardiography) in most patients with suspected LVNC.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If echocardiography is nondiagnostic and CMR is nondiagnostic or unavailable or not feasible due to presence of a contraindication, we suggest cardiac computed tomography (CT).</p><p></p><p class="bulletIndent1">Since multiple imaging modalities may be required to diagnose LVNC, the diagnosis is often delayed. In an early case series from Switzerland describing 16 patients, the mean time from the onset of symptoms to the correct diagnosis was 3.5 years [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other causes of noncompacted myocardium should be excluded. The differential diagnosis of LVNC includes other cardiomyopathies, altered phenotype associated with by physiologic or pathologic changes in loading conditions, and as a transient phenotype associated with other pathologic disorders.</p><p></p><p>Given the association between noncompacted myocardium and neuromuscular disorders, we screen patients with criteria for LVNC for neuromuscular disorder by physical examination, family history (focusing particularly on neurologic disease), and serum creatine kinase level. If this evaluation raises concern about a possible neuromuscular disorder, the patient is referred to a neurologist. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H12"><span class="h2">Echocardiography</span></p><p class="headingAnchor" id="H256133495"><span class="h3">Echocardiography criteria</span><span class="headingEndMark"> — </span>Echocardiography is the test most commonly used both to establish the diagnosis of LVNC and as an aid during follow-up  (<a class="graphic graphic_diagnosticimage graphicRef94919 graphicRef94917 graphicRef94918" href="/d/graphic/94919.html" rel="external">image 1A-C</a>) [<a href="#rid13">13,58</a>]. For diagnosis of LVNC using echocardiography, we use the Jenni criteria, which are the most widely accepted validated criteria. Alternatively, some clinicians use the Chin or Stöllberger criteria, which have also been validated.</p><p class="bulletIndent1"><span class="glyph">●</span>The Jenni criteria were developed based upon echocardiographic appearance with pathologic confirmation in seven patients with LVNC; the criteria were validated in a second population [<a href="#rid58">58-60</a>]. The criteria are assessed in the parasternal short-axis view at base, mid, and apical levels.</p><p></p><p class="bulletIndent1">The presence of all four of the following echocardiographic criteria are required for diagnosis:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A thickened LV wall consisting of two layers: a thin compacted epicardial layer and a markedly thickened endocardial layer with numerous prominent trabeculations and deep recesses with a maximum ratio of noncompacted to compacted myocardium &gt;2:1 at <strong>end-systole</strong> in the parasternal short-axis view  (<a class="graphic graphic_diagnosticimage graphicRef59614" href="/d/graphic/59614.html" rel="external">image 2</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Color Doppler evidence of flow within the deep intertrabecular recesses.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prominent trabecular meshwork in the LV apex or midventricular segments of the inferior and lateral wall and also affecting the right ventricle.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Compacted wall thickness ≤8.1 mm. The criterion of maximal systolic compacta thickness of ≤8.1 mm was found to be very specific for myocardial thickening in LVNC compared to normal controls or patients with aortic stenosis [<a href="#rid60">60</a>].</p><p></p><p>In addition, hypokinesis of noncompacted segments and possibly other adjoining segments may be present.</p><p class="bulletIndent1"><span class="glyph">●</span>The Chin criterion is based upon observations from eight patients [<a href="#rid61">61</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The presence of X/Y ≤0.5, where X is the distance from the epicardial surface to the trough of the trabecular recess and Y is the distance from the epicardial surface to peak of trabeculation. This criterion is applied to trabeculae at the LV apex on subxiphoid or apical four-chamber views at <strong>end-diastole</strong>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stöllberger criteria emphasize hypertrabeculation [<a href="#rid62">62</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>More than three trabeculations protruding from the LV wall, apically to the papillary muscles, visible in a single image plane.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intertrabecular spaces perfused from the ventricular cavity, visualized on color Doppler imaging.</p><p></p><p>The role for contrast echocardiography has been incompletely evaluated in LVNC; in our practice, we routinely use contrast echocardiography for diagnosis of LVNC in patients with suboptimal image quality to help differentiate LVNC from apical HCM, eosinophilic endomyocardial disease, and from apical thrombi [<a href="#rid63">63</a>].</p><p>A role for three-dimensional echocardiography in LVNC has not been established. A three-dimensional echocardiographic study found significantly higher trabeculated LV volume and trabeculated LV volume normalized by LV end-diastolic volume in patients with LVNC compared to healthy controls and athletes [<a href="#rid64">64</a>].</p><p class="headingAnchor" id="H14"><span class="h3">Other echocardiographic findings</span><span class="headingEndMark"> — </span>Nonspecific findings that may be seen on echocardiography include reduced global LV systolic function, diastolic dysfunction, LV thrombi, and abnormal papillary muscle structure [<a href="#rid13">13</a>]. Absence of well-defined papillary muscles is a very typical finding of LVNC [<a href="#rid64">64</a>].</p><p>Tissue Doppler imaging has been used to assess patients with LVNC. The diagnostic benefit of strain and strain rate imaging and speckle tracking in LVNC has yet to be determined.</p><p>As noted above, the echocardiographic appearance of isolated LVNC is heterogenous, including dilated forms, hypertrophic variant, and restrictive types [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H1971328140"><span class="h3">Cardiovascular magnetic resonance imaging</span><span class="headingEndMark"> — </span>CMR is generally used to aid in the diagnosis of LVNC when echocardiographic findings are inconclusive. In addition, since CMR provides morphologic information (including identification of fibrosis by late gadolinium enhancement (LGE) which may have prognostic implications) that differs from that provided by echocardiography, we perform it once in most patients to confirm the diagnosis of LVNC and repeat it as indicated during follow-up as a component of the evaluation for evolving clinical symptoms and complications. (See  <a class="medical medical_review" href="/d/html/120616.html" rel="external">"Isolated left ventricular noncompaction in adults: Management and prognosis", section on 'Prognosis'</a>.)</p><p class="headingAnchor" id="H2424983546"><span class="h4">CMR criteria</span><span class="headingEndMark"> — </span>Studies suggest that optimum criteria for diagnosis of LVNC by CMR differ slightly from the above-described echocardiographic criteria [<a href="#rid66">66-68</a>]. In our practice we use these CMR criteria with caution, as these criteria may overestimate the presence of LVNC. As there is no real gold-standard, sensitivity and specificity of CMR is difficult to assess.</p><p>LVNC is characterized by a noncompacted myocardial layer in the LV, a finding that can be readily identified by CMR  (<a class="graphic graphic_diagnosticimage graphicRef94977 graphicRef94979 graphicRef94918" href="/d/graphic/94977.html" rel="external">image 1C-E</a>). Trabeculations and recesses appear differently on CMR compared to echocardiography and CT. CMR offers good spatial resolution of all LV segments, including the apex and lateral wall. Quantitative criteria are helpful since regions of apparent noncompaction (two-layered appearance of trabeculated and compacted myocardium) are common in both LVNC and in other groups with and without cardiovascular disease [<a href="#rid66">66</a>].</p><p>CMR criteria for LVNC are evolving and data are needed to identify which diagnostic criteria perform best in various populations and best predict adverse outcomes [<a href="#rid69">69</a>]. The following end-diastolic and end-systolic CMR criteria have been proposed:</p><p class="bulletIndent1"><span class="glyph">●</span>A maximum end-diastolic noncompacted to compacted myocardial thickness ratio of &gt;2.3 was the best criterion for LVNC in a study of seven patients with LVNC and 170 healthy volunteers, athletes, and patients with dilated or HCM, hypertensive heart disease, or aortic stenosis  (<a class="graphic graphic_diagnosticimage graphicRef94977" href="/d/graphic/94977.html" rel="external">image 1D</a>) [<a href="#rid66">66</a>]. This ratio was assessed in three long-axis views and yielded a sensitivity of 86 percent and specificity of 99 percent for LVNC.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A trabeculated LV mass &gt;20 percent of global LV mass was identified as a criterion for LVNC in a study of 16 patients with LVNC, 16 patients with HCM, and 16 control subjects [<a href="#rid70">70</a>]. This metric yielded a sensitivity of 94 percent and a specificity of 94 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fractal dimension as a quantitative measure of trabeculation is high in LVNC and may be very accurate and reproducible [<a href="#rid71">71</a>]. However, the fractal dimension in the apical third of the LV is higher in healthy Black patients than in White patients.</p><p></p><p>A retrospective study found that an end-systolic noncompacted to compacted (thickness) ratio ≥2.0 was more strongly associated with HF and with adverse events (HF, death, HF readmission, embolic events, and ventricular arrhythmias) than other criteria for LVNC (end-diastolic noncompacted to compacted ratio ≥2.3 or trabeculated to global LV mass ratio &gt;40 percent) [<a href="#rid72">72</a>]. In this study, a 40 percent (rather than 20 percent) cutoff was used for trabeculated to global LV mass because papillary muscle was included in the trabeculated mass.</p><p>Various CMR criteria have differing sensitivity and specificity for LVNC. In a study comparing four different CMR criteria for LVNC, 3 to 39 percent of patients referred for CMR fulfilled LVNC criteria [<a href="#rid73">73</a>]. The Stöllberger echocardiographic criteria for LVNC (see <a class="local">'Echocardiography'</a> above) may be insensitive when applied to CMR [<a href="#rid68">68</a>]. In a series of 19 LVNC patients diagnosed by echocardiography using the Stöllberger criteria, only nine met these criteria on CMR (obtained in short- and long-axis views). However, the overall CMR morphologic appearance in all cases confirmed the diagnosis of LVNC.</p><p>CMR may be superior to standard echocardiography in assessing the extent of noncompaction as suggested by a small study comparing CMR with echocardiography in 16 patients with LVNC [<a href="#rid74">74</a>]. All 17 left ventricular segments could be analyzed by CMR whereas 88 percent of segments could be analyzed by echocardiography at end-diastole and 87 percent of segments could be analyzed by echocardiography at end-systole. A two-layer structure was identified in more segments by CMR than by the echocardiographic methods. There was no significant difference between the maximum ratio of noncompacted/compacted layers by CMR and echocardiography at end-diastole. Echocardiography at end systole underestimated the ratio of noncompacted/compacted layers compared to CMR.</p><p class="headingAnchor" id="H3984487665"><span class="h4">Late gadolinium enhancement</span><span class="headingEndMark"> — </span>Myocardial fibrosis or scar detected by late gadolinium enhancement (LGE, also known as delayed hyperenhancement) of trabeculae has been observed in some patients with LVNC and may have prognostic value [<a href="#rid75">75</a>]. LGE distribution in patients fulfilling LVNC criteria can be very heterogeneous, which suggests that there are several distinct cardiomyopathic processes responsible for LVNC [<a href="#rid76">76</a>]. A study in patients with LVNC found that diffuse fibrosis reflected by T1 mapping on CMR was associated with ventricular arrhythmias and myocardial dysfunction [<a href="#rid77">77</a>]. Another study involving 98 patients with LVNC showed that noncompacted mass did not predict adverse events, but, in patients with impaired LV function and/or LV LGE, the risk of MACE was high [<a href="#rid78">78</a>].</p><p>The potential prognostic value of LGE is discussed separately. (See  <a class="medical medical_review" href="/d/html/120616.html" rel="external">"Isolated left ventricular noncompaction in adults: Management and prognosis", section on 'Prognosis'</a>.)</p><p>General use and risks of gadolinium contrast for CMR are discussed separately. (See  <a class="medical medical_review" href="/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging"</a> and  <a class="medical medical_review" href="/d/html/113082.html" rel="external">"Patient evaluation before gadolinium contrast administration for magnetic resonance imaging"</a>.)</p><p class="headingAnchor" id="H99074840"><span class="h3">RV involvement</span><span class="headingEndMark"> — </span>The presence of noncompaction of the right ventricular (RV) myocardium is often difficult to confirm by imaging. A CMR study found that LVNC is associated with increased trabeculations of the RV apex and that RV dysfunction in an LVNC population is associated with adverse clinical events [<a href="#rid79">79</a>]. The same impact on prognosis of LVNC in patients with RV involvement was shown by echocardiography [<a href="#rid79">79</a>].</p><p class="headingAnchor" id="H1195350925"><span class="h2">Other cardiac tests</span><span class="headingEndMark"> — </span>In patients with nondiagnostic echocardiography and nondiagnostic or unavailable CMR results, we suggest cardiac CT.</p><p>In patients with LVNC who are candidates for cardiac transplantation, the diagnosis is generally made prior to transplantation. Characteristic cardiac abnormalities have been described in explanted hearts. (See <a class="local">'Findings at cardiac explant or autopsy'</a> below.)</p><p class="headingAnchor" id="H256132882"><span class="h3">Computed tomography</span><span class="headingEndMark"> — </span>CT is a potential alternative method of diagnosing LVNC if the echocardiogram is nondiagnostic and CMR is nondiagnostic or unavailable. A preliminary multidetector CT study of eight patients with LVNC (established by echocardiography or CMR), 51 patients with cardiovascular disease, and 20 controls without cardiovascular disease found that an end-diastolic noncompacted to compacted ratio of &gt;2.3 on CT long-axis views best identified LVNC [<a href="#rid80">80</a>].</p><p class="headingAnchor" id="H17"><span class="h3">Findings at cardiac explant or autopsy</span><span class="headingEndMark"> — </span>Upon examination at autopsy or cardiac explant at cardiac transplantation, a variety of gross patterns of noncompaction have been noted, including anastomosing broad trabeculae, coarse trabeculae resembling multiple papillary muscles, and sponge-like, interlacing, smaller muscle bundles. Perhaps the absence of well-formed papillary muscles is the best clue to the diagnosis  (<a class="graphic graphic_picture graphicRef57125" href="/d/graphic/57125.html" rel="external">picture 1</a>) [<a href="#rid81">81</a>]. Since data are limited, the prevalence of these findings is not known. Histologic findings are nonspecific, and interstitial fibrosis can be found adjacent to normal myocytes [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H508413337"><span class="h2">Limitations</span><span class="headingEndMark"> — </span>Since there is no gold standard for diagnosis of LVNC, the sensitivity and specificity of morphologic criteria are uncertain. As discussed below, morphologic criteria for LVNC may be nonspecific, particularly in athletes and Black individuals [<a href="#rid15">15</a>]. Diagnostic criteria for LVNC are evolving and require further standardization in relation to clinical end points that are relevant to management and prognosis. There is limited concordance among the various echocardiographic and other imaging modality criteria for LVNC [<a href="#rid15">15,21</a>]. (See <a class="local">'Echocardiography'</a> above.)</p><p>While LVNC is an "unclassified" cardiomyopathy  (<a class="graphic graphic_table graphicRef64479" href="/d/graphic/64479.html" rel="external">table 1A</a> and <a class="graphic graphic_table graphicRef74268" href="/d/graphic/74268.html" rel="external">table 1B</a>) [<a href="#rid3">3</a>], most patients with LVNC also have features of other morphologic categories of cardiomyopathy, particularly dilated cardiomyopathy, occasionally HCM (especially the apical variant), or rarely restrictive cardiomyopathy [<a href="#rid30">30,34,82,83</a>]. Within the same family, the phenotypic expression can vary considerably [<a href="#rid84">84</a>].</p><p>As an example, lack of specificity of most of the above echocardiographic LVNC criteria [<a href="#rid58">58,61,62</a>] was noted in a retrospective study of 199 patients with systolic dysfunction referred to an HF clinic and 60 normal controls [<a href="#rid15">15</a>]. In this study, 24 percent of patients with systolic dysfunction and five (including four Black patients) of the 60 normal controls fulfilled one or more of the three sets of echocardiographic criteria for LVNC. Despite considerable agreement, there remains substantial interobserver disagreement on the diagnosis of LVNC by echocardiography in up to 35 percent of cases [<a href="#rid85">85</a>].</p><p>In a study with 1146 athletes, 8.1 percent of athletes fulfilled LVNC criteria with no adverse events during a mean four-year follow-up [<a href="#rid86">86</a>]. Therefore, in athletes, the diagnosis of LVNC should be made with caution.</p><p>The prevalence of individuals with LVNC was examined among 2742 participants (more than 50 percent with hypertension) in the MESA (Multi-Ethnic Study of Atherosclerosis) study [<a href="#rid87">87</a>]. By CMR, 25.7 percent fulfilled LVNC criteria. The maximal NC/C ratio and changes in end-systolic volume index were examined. Greater extent of or excessive LV trabeculation at end-diastole was common and appeared to be benign and was not associated with deterioration in LV volumes or function during 9.5 years follow-up.</p><p>Given this finding, it has been proposed that definitive diagnosis of LVNC should include short-axis echocardiographic (Jenni [<a href="#rid58">58</a>]) or CMR (Jacquier [<a href="#rid70">70</a>]) criterion plus one of the following features: LVNC diagnosed in another family member; regional wall motion abnormalities; LVNC-related complications (arrhythmia, HF, or thromboembolism); and being a carrier of a pathogenic mutation in a gene previously associated with LVNC in various families [<a href="#rid88">88</a>].</p><p class="headingAnchor" id="H628939569"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>LVNC is diagnosed using criteria that are evolving and have limited specificity, so care must be taken to distinguish LVNC from other conditions with similar morphology. The differential diagnosis of LVNC includes other cardiomyopathies, altered phenotype associated with physiologic or pathologic changes in loading conditions, and as a transient phenotype associated with other pathologic disorders.</p><p>The differential diagnosis of LVNC includes other cardiomyopathies  (<a class="graphic graphic_table graphicRef64479 graphicRef74268" href="/d/graphic/64479.html" rel="external">table 1A-B</a>) such as dilated cardiomyopathy, HCM (particularly the apical form), arrhythmogenic RV cardiomyopathy [<a href="#rid89">89</a>], and restrictive cardiomyopathy (including Fabry disease); endomyocardial fibrosis; and aberrant chordae tendineae [<a href="#rid15">15,90,91</a>]. Since there is no gold standard for diagnosis of LVNC, LVNC is distinguished from other cardiomyopathies based upon morphologic criteria for noncompaction or hypertrabeculation. LVNC is diagnosed when the morphologic criteria for LVNC are met, though morphologic criteria for another type of cardiomyopathy may also be present [<a href="#rid92">92</a>]. Genetic studies suggest overlap between LVNC and other types of cardiomyopathy. In patients with features of both LVNC and another type of cardiomyopathy (eg, unexplained LV hypertrophy with echocardiographic or other clinical features suggestive of cardiac Fabry disease), both diagnoses should be considered [<a href="#rid90">90</a>]. (See <a class="local">'Limitations'</a> above and  <a class="medical medical_review" href="/d/html/4943.html" rel="external">"Definition and classification of the cardiomyopathies"</a> and <a class="local">'Genetics'</a> above.)</p><p>The morphologic appearance of LVNC can also occasionally be seen with altered loading conditions, with hypertensive heart disease, in healthy individuals, particularly athletes, pregnant women, and Black individuals [<a href="#rid15">15,32,86</a>], as well as in individuals with various hematologic disorders [<a href="#rid93">93</a>]. A reversible increase in LV trabeculations that fulfill criteria for LVNC can occur in up to 8 percent of pregnant women; most of the changes resolve within two years [<a href="#rid32">32</a>].</p><p>Additionally, LVNC can occur as a transient phenomenon in patients with other disorders such as myocarditis [<a href="#rid94">94</a>], amyloidosis [<a href="#rid92">92</a>], or systemic lupus erythematosus [<a href="#rid95">95</a>].This transient phenotype should be distinguished from isolated LVNC.</p><p>Isolated LVNC is defined as occurring in the absence of other cardiac or noncardiac congenital abnormalities. Thus, the diagnosis is made after exclusion of disorders with similar myocardial abnormalities associated with other clinical features. Noncompacted myocardium is seen in the following clinical settings:</p><p class="bulletIndent1"><span class="glyph">●</span>Noncompacted myocardium with intramyocardial sinusoids and coronary artery fistulae is observed in some patients with congenital RV or LV outflow tract abnormalities, such as pulmonary atresia with intact ventricular septum, tetralogy of Fallot, or aortic coarctation [<a href="#rid96">96-98</a>]. Coronary artery abnormalities are common in patients with RV or LV outflow tract abnormalities. In contrast, patients with LVNC usually have normal coronary artery circulation, although coronary fistulae have been rarely reported [<a href="#rid99">99</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Noncompacted myocardium is occasionally seen accompanying other congenital cardiac disorders, such as Ebstein anomaly, bicuspid aortic valve, atrial and ventricular septal defects, patent ductus arteriosus, coarctation, aorta-to-LV tunnel, congenitally corrected transposition, hypoplastic left heart syndrome, and isomerism of the atrial appendages [<a href="#rid98">98,100-104</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Noncompacted myocardium has also been identified in patients with neuromuscular disorders, including Barth syndrome, muscular dystrophies (including Becker muscular dystrophy, Duchenne muscular dystrophy, dystrobrevinopathy, Emery–Dreifuss muscular dystrophy, myotonic dystrophy types 1 and 2, and zaspopathy) and neuropathies (including Charcot-Marie-Tooth disease type 1A), metabolic myopathies (including mitochondrial disorder), and other genetic syndromes, including Melnick-Fraser syndrome, and nail-patella syndrome [<a href="#rid105">105,106</a>].</p><p></p><p class="headingAnchor" id="H3486175146"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/115416.html" rel="external">"Society guideline links: Cardiomyopathy"</a>.)</p><p class="headingAnchor" id="H20"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Although left ventricular noncompaction (LVNC) has been categorized as an "unclassified" cardiomyopathy, mounting evidence points to reclassification of LVNC as a distinct but not always pathological phenotype. By definition, isolated LVNC occurs in the absence of other cardiac or noncardiac congenital abnormalities. (See <a class="local">'Definitions'</a> above and <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>LVNC is characterized by the following features (see <a class="local">'Definitions'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A myocardial wall with prominent trabeculae with two layers consisting of noncompacted myocardium and a thin compacted layer of myocardium  (<a class="graphic graphic_picture graphicRef57125" href="/d/graphic/57125.html" rel="external">picture 1</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Continuity between the LV cavity and the deep intertrabecular recesses.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The clinical manifestations of LVNC are variable and cardiac symptoms and signs may not be present. Clinical features may include dyspnea, chest pain, palpitations, syncope, or an abnormal electrocardiogram or echocardiogram. Complications include heart failure, thromboembolism, and arrhythmias. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>LVNC is diagnosed using morphologic criteria which should be applied with caution, particularly in individuals who lack other clinical manifestations of LVNC. The range of LVNC includes severe disease and mild phenotypes that may be difficult to distinguish from normal variants. Preventing overdiagnosis should be a priority. (See <a class="local">'Approach to diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of LVNC is usually established by identifying morphologic diagnostic criteria on transthoracic echocardiography. We use the Jenni criteria for echocardiographic diagnosis of LVNC, which are the most commonly used criteria, although all criteria are subject to limitations. (See <a class="local">'Echocardiography'</a> above and <a class="local">'Limitations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular magnetic resonance (CMR) imaging is suggested in most patients with known or suspected LVNC. CMR provides structural information (eg identification of fibrosis by late gadolinium enhancement) that differs from that provided by echocardiography and may have prognostic value. (See <a class="local">'Cardiovascular magnetic resonance imaging'</a> above and  <a class="medical medical_review" href="/d/html/120616.html" rel="external">"Isolated left ventricular noncompaction in adults: Management and prognosis", section on 'Prognosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Since LVNC is diagnosed using criteria that are evolving and have limited specificity, care must be taken to distinguish LVNC from other conditions with similar morphology. The differential diagnosis of LVNC includes other cardiomyopathies, altered phenotype associated with by physiologic or pathologic changes in loading conditions, and as a transient phenotype associated with other pathologic disorders. (See <a class="local">'Differential diagnosis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Soliman OI, McGhie J, ten Cate FJ, et al. Multimodality imaging, diagnostic challenges and proposed diagnostic algorithm for noncompaction cardiomyopathy. In: Noncompaction Cardiomyopathy, Caliskan K, Soliman OI, ten Cate FJ (Eds), Springer, 2019. p.17.</li><li><a class="nounderline abstract_t">Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113:1807.</a></li><li><a class="nounderline abstract_t">Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29:270.</a></li><li><a class="nounderline abstract_t">Stöllberger C, Finsterer J. Outcome of left ventricular hypertrabeculation/noncompaction in children. Am J Cardiol 2005; 96:607; author reply 607.</a></li><li><a class="nounderline abstract_t">Hershberger RE, Morales A, Cowan J. Is Left Ventricular Noncompaction a Trait, Phenotype, or Disease? The Evidence Points to Phenotype. Circ Cardiovasc Genet 2017; 10.</a></li><li><a class="nounderline abstract_t">Ritter M, Oechslin E, Sütsch G, et al. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc 1997; 72:26.</a></li><li><a class="nounderline abstract_t">Weiford BC, Subbarao VD, Mulhern KM. Noncompaction of the ventricular myocardium. Circulation 2004; 109:2965.</a></li><li><a class="nounderline abstract_t">Arbustini E, Weidemann F, Hall JL. Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases? J Am Coll Cardiol 2014; 64:1840.</a></li><li><a class="nounderline abstract_t">Pignatelli RH, McMahon CJ, Dreyer WJ, et al. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 2003; 108:2672.</a></li><li><a class="nounderline abstract_t">Aras D, Tufekcioglu O, Ergun K, et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J Card Fail 2006; 12:726.</a></li><li><a class="nounderline abstract_t">Stanton C, Bruce C, Connolly H, et al. Isolated left ventricular noncompaction syndrome. Am J Cardiol 2009; 104:1135.</a></li><li><a class="nounderline abstract_t">Ross SB, Jones K, Blanch B, et al. A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults. Eur Heart J 2020; 41:1428.</a></li><li><a class="nounderline abstract_t">Oechslin EN, Attenhofer Jost CH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000; 36:493.</a></li><li><a class="nounderline abstract_t">Kovacevic-Preradovic T, Jenni R, Oechslin EN, et al. Isolated left ventricular noncompaction as a cause for heart failure and heart transplantation: a single center experience. Cardiology 2009; 112:158.</a></li><li><a class="nounderline abstract_t">Kohli SK, Pantazis AA, Shah JS, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 2008; 29:89.</a></li><li><a class="nounderline abstract_t">Kawel N, Nacif M, Arai AE, et al. Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging 2012; 5:357.</a></li><li><a class="nounderline abstract_t">Henderson DJ, Anderson RH. The development and structure of the ventricles in the human heart. Pediatr Cardiol 2009; 30:588.</a></li><li><a class="nounderline abstract_t">Chen H, Zhang W, Li D, et al. Analysis of ventricular hypertrabeculation and noncompaction using genetically engineered mouse models. Pediatr Cardiol 2009; 30:626.</a></li><li><a class="nounderline abstract_t">Sedmera D, Pexieder T, Vuillemin M, et al. Developmental patterning of the myocardium. Anat Rec 2000; 258:319.</a></li><li><a class="nounderline abstract_t">Piga A, Longo F, Musallam KM, et al. Left ventricular noncompaction in patients with β-thalassemia: uncovering a previously unrecognized abnormality. Am J Hematol 2012; 87:1079.</a></li><li><a class="nounderline abstract_t">Murphy RT, Thaman R, Blanes JG, et al. Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J 2005; 26:187.</a></li><li><a class="nounderline abstract_t">Zaragoza MV, Arbustini E, Narula J. Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology. Curr Opin Pediatr 2007; 19:619.</a></li><li><a class="nounderline abstract_t">Gati S, Rajani R, Carr-White GS, Chambers JB. Adult left ventricular noncompaction: reappraisal of current diagnostic imaging modalities. JACC Cardiovasc Imaging 2014; 7:1266.</a></li><li><a class="nounderline abstract_t">Cannie D, Elliott P. The genetics of left ventricular noncompaction. Curr Opin Cardiol 2021; 36:301.</a></li><li><a class="nounderline abstract_t">Kelley-Hedgepeth A, Towbin JA, Maron MS. Images in cardiovascular medicine. Overlapping phenotypes: left ventricular noncompaction and hypertrophic cardiomyopathy. Circulation 2009; 119:e588.</a></li><li><a class="nounderline abstract_t">Monserrat L, Barriales-Villa R, Hermida-Prieto M. Apical hypertrophic cardiomyopathy and left ventricular non-compaction: two faces of the same disease. Heart 2008; 94:1253.</a></li><li><a class="nounderline abstract_t">van Waning JI, Caliskan K, Hoedemaekers YM, et al. Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy. J Am Coll Cardiol 2018; 71:711.</a></li><li><a class="nounderline abstract_t">van Waning JI, Moesker J, Heijsman D, et al. Systematic Review of Genotype-Phenotype Correlations in Noncompaction Cardiomyopathy. J Am Heart Assoc 2019; 8:e012993.</a></li><li class="breakAll">http://omim.org/ (Accessed on December 10, 2014).</li><li><a class="nounderline abstract_t">Ichida F, Tsubata S, Bowles KR, et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 2001; 103:1256.</a></li><li><a class="nounderline abstract_t">Richard P, Ader F, Roux M, et al. Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity. Clin Genet 2019; 95:356.</a></li><li><a class="nounderline abstract_t">Gati S, Papadakis M, Papamichael ND, et al. Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations. Circulation 2014; 130:475.</a></li><li><a class="nounderline abstract_t">Parent JJ, Towbin JA, Jefferies JL. Fibrillin-1 Gene Mutations in Left Ventricular Non-compaction Cardiomyopathy. Pediatr Cardiol 2016; 37:1123.</a></li><li><a class="nounderline abstract_t">Monserrat L, Hermida-Prieto M, Fernandez X, et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J 2007; 28:1953.</a></li><li><a class="nounderline abstract_t">Klaassen S, Probst S, Oechslin E, et al. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 2008; 117:2893.</a></li><li><a class="nounderline abstract_t">Probst S, Oechslin E, Schuler P, et al. Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype. Circ Cardiovasc Genet 2011; 4:367.</a></li><li><a class="nounderline abstract_t">Hoedemaekers YM, Caliskan K, Majoor-Krakauer D, et al. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J 2007; 28:2732.</a></li><li><a class="nounderline abstract_t">Chang B, Nishizawa T, Furutani M, et al. Identification of a novel TPM1 mutation in a family with left ventricular noncompaction and sudden death. Mol Genet Metab 2011; 102:200.</a></li><li><a class="nounderline abstract_t">Marakhonov AV, Brodehl A, Myasnikov RP, et al. Noncompaction cardiomyopathy is caused by a novel in-frame desmin (DES) deletion mutation within the 1A coiled-coil rod segment leading to a severe filament assembly defect. Hum Mutat 2019; 40:734.</a></li><li><a class="nounderline abstract_t">Li S, Zhang C, Liu N, et al. Titin-truncating variants are associated with heart failure events in patients with left ventricular non-compaction cardiomyopathy. Clin Cardiol 2019; 42:530.</a></li><li><a class="nounderline abstract_t">Bleyl SB, Mumford BR, Thompson V, et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 1997; 61:868.</a></li><li><a class="nounderline abstract_t">Xing Y, Ichida F, Matsuoka T, et al. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Mol Genet Metab 2006; 88:71.</a></li><li><a class="nounderline abstract_t">Spencer CT, Bryant RM, Day J, et al. Cardiac and clinical phenotype in Barth syndrome. Pediatrics 2006; 118:e337.</a></li><li><a class="nounderline abstract_t">Luxán G, Casanova JC, Martínez-Poveda B, et al. Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. Nat Med 2013; 19:193.</a></li><li><a class="nounderline abstract_t">Hermida-Prieto M, Monserrat L, Castro-Beiras A, et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am J Cardiol 2004; 94:50.</a></li><li><a class="nounderline abstract_t">Vatta M, Mohapatra B, Jimenez S, et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003; 42:2014.</a></li><li><a class="nounderline abstract_t">Sasse-Klaassen S, Probst S, Gerull B, et al. Novel gene locus for autosomal dominant left ventricular noncompaction maps to chromosome 11p15. Circulation 2004; 109:2720.</a></li><li><a class="nounderline abstract_t">Ohno S, Omura M, Kawamura M, et al. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction. Europace 2014; 16:1646.</a></li><li><a class="nounderline abstract_t">Brescia ST, Rossano JW, Pignatelli R, et al. Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center. Circulation 2013; 127:2202.</a></li><li><a class="nounderline abstract_t">Duru F, Candinas R. Noncompaction of ventricular myocardium and arrhythmias. J Cardiovasc Electrophysiol 2000; 11:493.</a></li><li><a class="nounderline abstract_t">Bhatia NL, Tajik AJ, Wilansky S, et al. Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview. J Card Fail 2011; 17:771.</a></li><li><a class="nounderline abstract_t">Joong A, Hayes DA, Anderson BR, et al. Comparison of Echocardiographic Diagnostic Criteria of Left Ventricular Noncompaction in a Pediatric Population. Pediatr Cardiol 2017; 38:1493.</a></li><li><a class="nounderline abstract_t">Menon SC, O'Leary PW, Wright GB, et al. Fetal and neonatal presentation of noncompacted ventricular myocardium: expanding the clinical spectrum. J Am Soc Echocardiogr 2007; 20:1344.</a></li><li><a class="nounderline abstract_t">Stöllberger C, Wegner C, Finsterer J. CHADS2- and CHA2DS2VASc scores and embolic risk in left ventricular hypertrabeculation/noncompaction. J Stroke Cerebrovasc Dis 2013; 22:709.</a></li><li><a class="nounderline abstract_t">Salerno JC, Chun TU, Rutledge JC. Sinus bradycardia, Wolff Parkinson White, and left ventricular noncompaction: an embryologic connection? Pediatr Cardiol 2008; 29:679.</a></li><li><a class="nounderline abstract_t">Ergul Y, Nisli K, Varkal MA, et al. Electrocardiographic findings at initial diagnosis in children with isolated left ventricular noncompaction. Ann Noninvasive Electrocardiol 2011; 16:184.</a></li><li><a class="nounderline abstract_t">Quarta G, Papadakis M, Donna PD, et al. Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease. Nat Rev Cardiol 2017; 14:102.</a></li><li><a class="nounderline abstract_t">Jenni R, Oechslin E, Schneider J, et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 2001; 86:666.</a></li><li><a class="nounderline abstract_t">Frischknecht BS, Attenhofer Jost CH, Oechslin EN, et al. Validation of noncompaction criteria in dilated cardiomyopathy, and valvular and hypertensive heart disease. J Am Soc Echocardiogr 2005; 18:865.</a></li><li><a class="nounderline abstract_t">Gebhard C, Stähli BE, Greutmann M, et al. Reduced left ventricular compacta thickness: a novel echocardiographic criterion for non-compaction cardiomyopathy. J Am Soc Echocardiogr 2012; 25:1050.</a></li><li><a class="nounderline abstract_t">Chin TK, Perloff JK, Williams RG, et al. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 1990; 82:507.</a></li><li><a class="nounderline abstract_t">Stöllberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002; 90:899.</a></li><li><a class="nounderline abstract_t">Lowery MH, Martel JA, Zambrano JP, et al. Noncompaction of the ventricular myocardium: the use of contrast-enhanced echocardiography in diagnosis. J Am Soc Echocardiogr 2003; 16:94.</a></li><li><a class="nounderline abstract_t">Caselli S, Autore C, Serdoz A, et al. Three-dimensional echocardiographic characterization of patients with left ventricular noncompaction. J Am Soc Echocardiogr 2012; 25:203.</a></li><li><a class="nounderline abstract_t">Towbin JA. Left ventricular noncompaction: a new form of heart failure. Heart Fail Clin 2010; 6:453.</a></li><li><a class="nounderline abstract_t">Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005; 46:101.</a></li><li><a class="nounderline abstract_t">Fazio G, Novo G, D'Angelo L, et al. Magnetic resonance in isolated noncompaction of the ventricular myocardium. Int J Cardiol 2010; 140:367.</a></li><li><a class="nounderline abstract_t">Stöllberger C, Kopsa W, Tscherney R, Finsterer J. Diagnosing left ventricular noncompaction by echocardiography and cardiac magnetic resonance imaging and its dependency on neuromuscular disorders. Clin Cardiol 2008; 31:383.</a></li><li><a class="nounderline abstract_t">Petersen SE. CMR and LV noncompaction: does it matter how we measure trabeculations? JACC Cardiovasc Imaging 2013; 6:941.</a></li><li><a class="nounderline abstract_t">Jacquier A, Thuny F, Jop B, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J 2010; 31:1098.</a></li><li><a class="nounderline abstract_t">Captur G, Muthurangu V, Cook C, et al. Quantification of left ventricular trabeculae using fractal analysis. J Cardiovasc Magn Reson 2013; 15:36.</a></li><li><a class="nounderline abstract_t">Stacey RB, Andersen MM, St Clair M, et al. Comparison of systolic and diastolic criteria for isolated LV noncompaction in CMR. JACC Cardiovasc Imaging 2013; 6:931.</a></li><li><a class="nounderline abstract_t">Ivanov A, Dabiesingh DS, Bhumireddy GP, et al. Prevalence and Prognostic Significance of Left Ventricular Noncompaction in Patients Referred for Cardiac Magnetic Resonance Imaging. Circ Cardiovasc Imaging 2017; 10.</a></li><li><a class="nounderline abstract_t">Thuny F, Jacquier A, Jop B, et al. Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography. Arch Cardiovasc Dis 2010; 103:150.</a></li><li><a class="nounderline abstract_t">Dodd JD, Holmvang G, Hoffmann U, et al. Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. AJR Am J Roentgenol 2007; 189:974.</a></li><li><a class="nounderline abstract_t">Wan J, Zhao S, Cheng H, et al. Varied distributions of late gadolinium enhancement found among patients meeting cardiovascular magnetic resonance criteria for isolated left ventricular non-compaction. J Cardiovasc Magn Reson 2013; 15:20.</a></li><li><a class="nounderline abstract_t">Araujo-Filho JAB, Assuncao AN Jr, Tavares de Melo MD, et al. Myocardial T1 mapping and extracellular volume quantification in patients with left ventricular non-compaction cardiomyopathy. Eur Heart J Cardiovasc Imaging 2018; 19:888.</a></li><li><a class="nounderline abstract_t">Femia G, Zhu D, Choudhary P, et al. Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults. Int J Cardiol 2021; 328:235.</a></li><li><a class="nounderline abstract_t">Stacey RB, Andersen M, Haag J, et al. Right ventricular morphology and systolic function in left ventricular noncompaction cardiomyopathy. Am J Cardiol 2014; 113:1018.</a></li><li><a class="nounderline abstract_t">Sidhu MS, Uthamalingam S, Ahmed W, et al. Defining left ventricular noncompaction using cardiac computed tomography. J Thorac Imaging 2014; 29:60.</a></li><li><a class="nounderline abstract_t">Burke A, Mont E, Kutys R, Virmani R. Left ventricular noncompaction: a pathological study of 14 cases. Hum Pathol 2005; 36:403.</a></li><li><a class="nounderline abstract_t">Rapezzi C, Leone O, Ferlito M, et al. Isolated ventricular non-compaction with restrictive cardiomyopathy. Eur Heart J 2006; 27:1927.</a></li><li><a class="nounderline abstract_t">Biagini E, Ragni L, Ferlito M, et al. Different types of cardiomyopathy associated with isolated ventricular noncompaction. Am J Cardiol 2006; 98:821.</a></li><li><a class="nounderline abstract_t">Johnson MT, Zhang S, Gilkeson R, et al. Intrafamilial variability of noncompaction of the ventricular myocardium. Am Heart J 2006; 151:1012.e7.</a></li><li><a class="nounderline abstract_t">Stöllberger C, Gerecke B, Engberding R, et al. Interobserver Agreement of the Echocardiographic Diagnosis of LV Hypertrabeculation/Noncompaction. JACC Cardiovasc Imaging 2015; 8:1252.</a></li><li><a class="nounderline abstract_t">Gati S, Chandra N, Bennett RL, et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart 2013; 99:401.</a></li><li><a class="nounderline abstract_t">Zemrak F, Ahlman MA, Captur G, et al. The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study. J Am Coll Cardiol 2014; 64:1971.</a></li><li><a class="nounderline abstract_t">Garcia-Pavia P, de la Pompa JL. Left ventricular noncompaction: a genetic cardiomyopathy looking for diagnostic criteria. J Am Coll Cardiol 2014; 64:1981.</a></li><li><a class="nounderline abstract_t">Wlodarska EK, Wozniak O, Konka M, et al. Isolated ventricular noncompaction mimicking arrhythmogenic right ventricular cardiomyopathy--a study of nine patients. Int J Cardiol 2010; 145:107.</a></li><li><a class="nounderline abstract_t">Azevedo O, Gaspar P, Sá Miranda C, et al. Left ventricular noncompaction in a patient with fabry disease: overdiagnosis, morphological manifestation of fabry disease or two unrelated rare conditions in the same patient? Cardiology 2011; 119:155.</a></li><li><a class="nounderline abstract_t">Oechslin E, Jenni R. Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity? Eur Heart J 2011; 32:1446.</a></li><li><a class="nounderline abstract_t">Paterick TE, Tercius AJ, Agarwal A, et al. Double jeopardy in the echocardiography laboratory: coexistence of two distinct cardiomyopathies? Echocardiography 2014; 31:931.</a></li><li><a class="nounderline abstract_t">Gati S, Papadakis M, Van Niekerk N, et al. Increased left ventricular trabeculation in individuals with sickle cell anaemia: physiology or pathology? Int J Cardiol 2013; 168:1658.</a></li><li><a class="nounderline abstract_t">Pfammatter JP, Paul T, Flik J, et al. [Q-fever associated myocarditis in a 14-year-old boy]. Z Kardiol 1995; 84:947.</a></li><li><a class="nounderline abstract_t">Rabelo CF, Batistella F, Godinho RN, et al. Systemic lupus erythematosus and transient left ventricular noncompaction. Acta Reumatol Port 2014; 39:274.</a></li><li><a class="nounderline abstract_t">LAUER RM, FINK HP, PETRY EL, et al. ANGIOGRAPHIC DEMONSTRATION OF INTRAMYOCARDIAL SINUSOIDS IN PULMONARY-VALVE ATRESIA WITH INTACT VENTRICULAR SEPTUM AND HYPOPLASTIC RIGHT VENTRICLE. N Engl J Med 1964; 271:68.</a></li><li><a class="nounderline abstract_t">Bonnet D, Gautier-Lhermitte I, Bonhoeffer P, Sidi D. Right ventricular myocardial sinusoidal-coronary artery connections in critical pulmonary valve stenosis. Pediatr Cardiol 1998; 19:269.</a></li><li><a class="nounderline abstract_t">Stähli BE, Gebhard C, Biaggi P, et al. Left ventricular non-compaction: prevalence in congenital heart disease. Int J Cardiol 2013; 167:2477.</a></li><li><a class="nounderline abstract_t">Dias V, Cabral S, Vieira M, et al. Noncompaction cardiomyopathy and multiple coronary arterioventricular fistulae: 1 or 2 distinct disease entities? J Am Coll Cardiol 2011; 57:e377.</a></li><li><a class="nounderline abstract_t">Agarwal A, Khandheria BK, Paterick TE, et al. Left ventricular noncompaction in patients with bicuspid aortic valve. J Am Soc Echocardiogr 2013; 26:1306.</a></li><li><a class="nounderline abstract_t">Ali SK. Unique features of non-compaction of the ventricular myocardium in Arab and African patients. Cardiovasc J Afr 2008; 19:241.</a></li><li><a class="nounderline abstract_t">Attenhofer Jost CH, Connolly HM, O'Leary PW, et al. Left heart lesions in patients with Ebstein anomaly. Mayo Clin Proc 2005; 80:361.</a></li><li><a class="nounderline abstract_t">Friedberg MK, Ursell PC, Silverman NH. Isomerism of the left atrial appendage associated with ventricular noncompaction. Am J Cardiol 2005; 96:985.</a></li><li><a class="nounderline abstract_t">Lilje C, Rázek V, Joyce JJ, et al. Complications of non-compaction of the left ventricular myocardium in a paediatric population: a prospective study. Eur Heart J 2006; 27:1855.</a></li><li><a class="nounderline abstract_t">Gerger D, Stöllberger C, Grassberger M, et al. Pathomorphologic findings in left ventricular hypertrabeculation/noncompaction of adults in relation to neuromuscular disorders. Int J Cardiol 2013; 169:249.</a></li><li><a class="nounderline abstract_t">Finsterer J, Stöllberger C, Towbin JA. Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors. Nat Rev Cardiol 2017; 14:224.</a></li></ol></div><div id="topicVersionRevision">Topic 4924 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Soliman OI, McGhie J, ten Cate FJ, et al. Multimodality imaging, diagnostic challenges and proposed diagnostic algorithm for noncompaction cardiomyopathy. In: Noncompaction Cardiomyopathy, Caliskan K, Soliman OI, ten Cate FJ (Eds), Springer, 2019. p.17.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16567565" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17916581" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16098323" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Outcome of left ventricular hypertrabeculation/noncompaction in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29212902" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Is Left Ventricular Noncompaction a Trait, Phenotype, or Disease? The Evidence Points to Phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9005281" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Isolated noncompaction of the myocardium in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15210614" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Noncompaction of the ventricular myocardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25443708" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14623814" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17174235" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19801037" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Isolated left ventricular noncompaction syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31143950" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10933363" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18663296" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Isolated left ventricular noncompaction as a cause for heart failure and heart transplantation: a single center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17993472" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22499849" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19225828" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The development and structure of the ventricles in the human heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19396388" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Analysis of ventricular hypertrabeculation and noncompaction using genetically engineered mouse models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10737851" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Developmental patterning of the myocardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22965286" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Left ventricular noncompaction in patients withβ-thalassemia: uncovering a previously unrecognized abnormality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15618076" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Natural history and familial characteristics of isolated left ventricular non-compaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18025927" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25496545" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Adult left ventricular noncompaction: reappraisal of current diagnostic imaging modalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33605617" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The genetics of left ventricular noncompaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19528341" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Images in cardiovascular medicine. Overlapping phenotypes: left ventricular noncompaction and hypertrophic cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18801786" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Apical hypertrophic cardiomyopathy and left ventricular non-compaction: two faces of the same disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29447731" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31771441" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Systematic Review of Genotype-Phenotype Correlations in Noncompaction Cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31771441" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Systematic Review of Genotype-Phenotype Correlations in Noncompaction Cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11238270" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30471092" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25006201" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27160103" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Fibrillin-1 Gene Mutations in Left Ventricular Non-compaction Cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17611253" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18506004" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Mutations in sarcomere protein genes in left ventricular noncompaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21551322" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17947214" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20965760" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Identification of a novel TPM1 mutation in a family with left ventricular noncompaction and sudden death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30908796" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Noncompaction cardiomyopathy is caused by a novel in-frame desmin (DES) deletion mutation within the 1A coiled-coil rod segment leading to a severe filament assembly defect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30851055" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Titin-truncating variants are associated with heart failure events in patients with left ventricular non-compaction cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9382097" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16427346" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16847078" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Cardiac and clinical phenotype in Barth syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23314057" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15219508" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14662268" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15173023" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Novel gene locus for autosomal dominant left ventricular noncompaction maps to chromosome 11p15.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24394973" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23633270" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10809508" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Noncompaction of ventricular myocardium and arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21872148" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28776136" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Comparison of Echocardiographic Diagnostic Criteria of Left Ventricular Noncompaction in a Pediatric Population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17764900" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Fetal and neonatal presentation of noncompacted ventricular myocardium: expanding the clinical spectrum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22142779" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : CHADS2- and CHA2DS2VASc scores and embolic risk in left ventricular hypertrabeculation/noncompaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17786379" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Sinus bradycardia, Wolff Parkinson White, and left ventricular noncompaction: an embryologic connection?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21496170" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Electrocardiographic findings at initial diagnosis in children with isolated left ventricular noncompaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27830773" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11711464" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16084340" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Validation of noncompaction criteria in dilated cardiomyopathy, and valvular and hypertensive heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22883316" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Reduced left ventricular compacta thickness: a novel echocardiographic criterion for non-compaction cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2372897" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Isolated noncompaction of left ventricular myocardium. A study of eight cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12372586" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12514644" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Noncompaction of the ventricular myocardium: the use of contrast-enhanced echocardiography in diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22154390" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Three-dimensional echocardiographic characterization of patients with left ventricular noncompaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20869646" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Left ventricular noncompaction: a new form of heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15992642" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19111359" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Magnetic resonance in isolated noncompaction of the ventricular myocardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18727062" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Diagnosing left ventricular noncompaction by echocardiography and cardiac magnetic resonance imaging and its dependency on neuromuscular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24029367" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : CMR and LV noncompaction: does it matter how we measure trabeculations?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20089517" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23663522" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Quantification of left ventricular trabeculae using fractal analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23769489" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Comparison of systolic and diastolic criteria for isolated LV noncompaction in CMR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28899950" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Prevalence and Prognostic Significance of Left Ventricular Noncompaction in Patients Referred for Cardiac Magnetic Resonance Imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20417446" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17885073" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23421977" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Varied distributions of late gadolinium enhancement found among patients meeting cardiovascular magnetic resonance criteria for isolated left ventricular non-compaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29518212" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Myocardial T1 mapping and extracellular volume quantification in patients with left ventricular non-compaction cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33309759" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24462071" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Right ventricular morphology and systolic function in left ventricular noncompaction cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23689383" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Defining left ventricular noncompaction using cardiac computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15892002" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Left ventricular noncompaction: a pathological study of 14 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16455669" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Isolated ventricular non-compaction with restrictive cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16950194" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Different types of cardiomyopathy associated with isolated ventricular noncompaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16644324" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Intrafamilial variability of noncompaction of the ventricular myocardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26563854" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Interobserver Agreement of the Echocardiographic Diagnosis of LV Hypertrabeculation/Noncompaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23393084" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25440091" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25440092" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Left ventricular noncompaction: a genetic cardiomyopathy looking for diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19581010" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Isolated ventricular noncompaction mimicking arrhythmogenic right ventricular cardiomyopathy--a study of nine patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21952291" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Left ventricular noncompaction in a patient with fabry disease: overdiagnosis, morphological manifestation of fabry disease or two unrelated rare conditions in the same patient?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21285074" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24447051" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Double jeopardy in the echocardiography laboratory: coexistence of two distinct cardiomyopathies?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23582434" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Increased left ventricular trabeculation in individuals with sickle cell anaemia: physiology or pathology?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8571646" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : [Q-fever associated myocarditis in a 14-year-old boy].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24863427" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Systemic lupus erythematosus and transient left ventricular noncompaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14149256" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : ANGIOGRAPHIC DEMONSTRATION OF INTRAMYOCARDIAL SINUSOIDS IN PULMONARY-VALVE ATRESIA WITH INTACT VENTRICULAR SEPTUM AND HYPOPLASTIC RIGHT VENTRICLE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9568230" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Right ventricular myocardial sinusoidal-coronary artery connections in critical pulmonary valve stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22704867" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Left ventricular non-compaction: prevalence in congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21679847" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Noncompaction cardiomyopathy and multiple coronary arterioventricular fistulae: 1 or 2 distinct disease entities?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24044978" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Left ventricular noncompaction in patients with bicuspid aortic valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18997984" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Unique features of non-compaction of the ventricular myocardium in Arab and African patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15757018" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Left heart lesions in patients with Ebstein anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16188529" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Isomerism of the left atrial appendage associated with ventricular noncompaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16818458" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Complications of non-compaction of the left ventricular myocardium in a paediatric population: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24182672" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Pathomorphologic findings in left ventricular hypertrabeculation/noncompaction of adults in relation to neuromuscular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28079110" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
